Filippo Artoni received his BS in Biology from the University of Washington (Seattle) in 2015. He began his research career at the Institute for Stem Cell and Regenerative Medicine (ISCRM, UW Medicine), working in the Ruohola-Baker lab (2014–2018) on the genetics of Drosophila tissue regeneration during aging.

He went on to pursue a PhD at the Max Planck Institute for Biology of Ageing in Cologne, Germany (2018–2023), in the Demetriades group, where he studied the pharmacology of rapamycin and other mTOR inhibitors using multi-omics approaches.

From 2024 to 2025, Filippo was a postdoctoral researcher at the Jean Mayer USDA Human Nutrition Research Center on Aging (HNRCA, Tufts University), where he contributed to the Dog Aging Project. His work focused on identifying risk factors that predispose dogs to age-related diseases using large-scale longitudinal models.

Filippo’s background bridges experimental biology and computational approaches, with a research focus on the mechanisms of aging and age-related diseases. He joined the Department of Molecular Epidemiology (MOLEPI) at Leiden University Medical Center as a postdoctoral researcher, where he is working on longevity biomarkers and the heterogeneity of responses to longevity interventions.